Manaʻo ʻia ʻo Multiplex Biomarker Imaging Market e ulu ma kahi CAGR ma kahi o 2022-2029

FMI 7 | eTurboNews | eTN
Avatar o Linda Hohnholz
i kakauia ma Linda Hohnholz

E like me ka ʻike o ka hōʻike, ka honua mākeke kiʻi biomarker multiplex ua manaʻo ʻia e ʻike i ka ulu nui ʻana i ka wā wānana, ma muli o ka ulu nui ʻana o ka noi no nā ʻenehana immunofluorescence holomua e kōkua i ka maʻi ʻoi aku ka maikaʻi a me ka hoʻokele ʻana i nā maʻi maʻi ma kahi pae cellular.

Ua kūʻai ʻia ka mākeke kiʻi biomarker multiplex honua i $ 422.1 Mn i 2021, a ke manaʻo ʻia e hoʻonui i kahi CAGR o 11.9% ma luna o ka wānana o 2022-2029.

ʻO nā mea nui o ka Multiplex Biomarker Imaging Market Study

  • Aia ke koi mau no ka immunofluorescence slide scanners, no ka mea, hāʻawi kēia mau mea i ke ʻano kiʻi kiʻekiʻe kiʻekiʻe, hilinaʻi, a me ka wikiwiki no ke kiʻi paheʻe holoʻokoʻa.
  • Manaʻo ʻia ʻo ʻAmelika ʻĀkau he mākeke maikaʻi no ka multix biomarker imaging, no ka hoʻomohala ʻana i nā ʻōnaehana olakino, nā kulekele aupuni maikaʻi, a me nā haʻawina kālā no ka noiʻi ʻana e ke aupuni.
  • Hoʻohana nui ʻia ka Immunostaining i ka ʻike ʻana i nā cell abnormal, e like me nā cell cancerous, a kōkua pū i ka hoʻomaopopo ʻana i ka hoʻohele a me ka localization o nā biomarkers a me nā protein i hōʻike ʻokoʻa ʻia i nā ʻāpana like ʻole o kahi kiko olaola.
  • ʻO ka kūleʻa pāʻoihana o ka mākeke kiʻi biomarkers multiplex e hilinaʻi nui ʻia i nā noiʻi noiʻi maʻi kanesa, hiki ke lawelawe i nā kumu he nui e like me ka ʻike ʻana i nā cell cancerous, ka hele ʻana o nā necrotic agents, a me ka loiloi ʻana i nā mea kūlohelohe a me ka hana ʻana i ka anatomy cellular.

ʻO nā mea pāʻani papa 1 e paʻa ma mua o 80% o ka loaʻa kālā

ʻO PerkinElmer, Bio-Rad, a me Thermo Fisher Scientific kekahi o nā mea pāʻani mākeke i ka mākeke kiʻi biomarker multiplex. Ke hoʻomau nei kēia mau mea hana i ka ʻāina o ka mākeke kiʻi biomarker multiplex ma muli o ko lākou manaʻo nui i ka hana hou ʻana o ka huahana, alakaʻi mākeke i ka hoʻolauna huahana, a me ka pūnaewele hoʻolaha ikaika me nā laboratories unuhi a me nā keʻena kula e hoʻonui i nā kūʻai.

Noi i TOC piha o keia hoike @ https://www.futuremarketinsights.com/toc/rep-gb-3526

Makemake ʻoe i nā ʻike hou aʻe?

Ua aʻo ʻo Future Market Insights i ka ulu ʻana o ka mākeke kiʻi biomarker multiplex mai 2014–2021, a hōʻike i nā kuhi koi no 2022–2029, ma ke kumu o nā ʻano mea (mea kani, lako polokalamu, a me nā lawelawe), ʻenehana kiʻi (IHC assays, FISH assays. , TMA assays), noi (noiʻi a me ka clinical diagnostics), a me ka mea hoʻohana hope (unuhi laboratories, biopharmaceutical company, and academic institute) ma ʻehiku mau ʻāina koʻikoʻi.

Multiplex Biomarker Imaging Market e ka ʻāpana

Ma ke ʻano ʻano mea:

  • Nā mea kani
    • Pūnaehana Kiʻi Pathology Quantitative
    • Immunofluorescence
    • Pūnaehana Kiʻi Multispectral
    • Pūnaehana Kiʻi Toponome
  • lako polokalamu
  • Services
    • Nā lawelawe hoʻokomo a hoʻohui
    • Nā lawelawe mālama

Ma ka ʻenehana kiʻi:

  • ʻIkepili Immunohistochemistry (IHC).
  • Hōʻike ʻo Fluorescent In Situ Hybridization (FISH).
  • Tissue Microarray (TMA) Assay

Ma ke noi:

  • Research
  • Nā Hoʻopaʻa Ola

Na ka mea hoʻohana hope:

  • Nā Laboratories unuhi
  • Nā Hui Lapaʻau Biopharmaceutical
  • Nā Hale Hoʻonaʻauao

Ma ka Hona:

  • North America
  • Lakina Amerika
  • ʻO Ke Komohana Komohana
  • HawaiianʻEulopa
  • ʻĀkia Pākīpika ʻē aʻe i Iapana (APEJ)
  • Iapana
  • Waena Hikina a me ʻApika

Kūʻai i kēia manawa @ https://www.futuremarketinsights.com/checkout/3526

Loaʻa punahele

No ka mea kākau

Avatar o Linda Hohnholz

Linda Hohnholz

Lunahooponopono no eTurboNews ma ka eTN HQ.

kakau
E hoʻomaopopo i
malihini
0 Comments
Nā ʻōlelo Hoʻohui Kūʻai
E nānā i nā ʻōlelo āpau
0
E aloha nui i kou mau manaʻo, e ʻoluʻolu.x
()
x
Kaʻana like i...